List of Tables
Table 1. Global Pulmonary Administration Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pulmonary Administration Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pulmonary Administration Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pulmonary Administration Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pulmonary Administration Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pulmonary Administration Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pulmonary Administration Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pulmonary Administration Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pulmonary Administration, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pulmonary Administration, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pulmonary Administration, Product Types and Applications
Table 12. Global Key Manufacturers of Pulmonary Administration, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pulmonary Administration Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pulmonary Administration Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pulmonary Administration Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pulmonary Administration Sales by Region (K Units), 2021–2026
Table 18. Global Pulmonary Administration Sales Market Share by Region (2021–2026)
Table 19. Global Pulmonary Administration Sales by Region (K Units), 2027–2032
Table 20. Global Pulmonary Administration Sales Market Share by Region (2027–2032)
Table 21. Global Pulmonary Administration Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pulmonary Administration Revenue Market Share by Region (2021–2026)
Table 23. Global Pulmonary Administration Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pulmonary Administration Revenue Market Share by Region (2027–2032)
Table 25. North America Pulmonary Administration Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pulmonary Administration Sales by Country (K Units), 2021–2026
Table 27. North America Pulmonary Administration Sales by Country (K Units), 2027–2032
Table 28. North America Pulmonary Administration Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pulmonary Administration Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pulmonary Administration Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pulmonary Administration Sales by Country (K Units), 2021–2026
Table 32. Europe Pulmonary Administration Sales by Country (K Units), 2027–2032
Table 33. Europe Pulmonary Administration Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pulmonary Administration Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pulmonary Administration Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pulmonary Administration Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pulmonary Administration Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pulmonary Administration Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pulmonary Administration Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pulmonary Administration Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pulmonary Administration Sales by Country (K Units), 2021–2026
Table 42. Latin America Pulmonary Administration Sales by Country (K Units), 2027–2032
Table 43. Latin America Pulmonary Administration Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pulmonary Administration Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pulmonary Administration Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pulmonary Administration Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pulmonary Administration Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pulmonary Administration Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pulmonary Administration Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pulmonary Administration Sales (K Units) by Type (2021–2026)
Table 51. Global Pulmonary Administration Sales (K Units) by Type (2027–2032)
Table 52. Global Pulmonary Administration Sales Market Share by Type (2021–2026)
Table 53. Global Pulmonary Administration Sales Market Share by Type (2027–2032)
Table 54. Global Pulmonary Administration Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pulmonary Administration Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pulmonary Administration Revenue Market Share by Type (2021–2026)
Table 57. Global Pulmonary Administration Revenue Market Share by Type (2027–2032)
Table 58. Global Pulmonary Administration Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pulmonary Administration Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pulmonary Administration Sales (K Units) by Application (2021–2026)
Table 61. Global Pulmonary Administration Sales (K Units) by Application (2027–2032)
Table 62. Global Pulmonary Administration Sales Market Share by Application (2021–2026)
Table 63. Global Pulmonary Administration Sales Market Share by Application (2027–2032)
Table 64. Global Pulmonary Administration Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pulmonary Administration Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pulmonary Administration Revenue Market Share by Application (2021–2026)
Table 67. Global Pulmonary Administration Revenue Market Share by Application (2027–2032)
Table 68. Global Pulmonary Administration Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pulmonary Administration Price (US$/Unit) by Application (2027–2032)
Table 70. Aptar Pharma Company Information
Table 71. Aptar Pharma Description and Business Overview
Table 72. Aptar Pharma Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Aptar Pharma Pulmonary Administration Product
Table 74. Aptar Pharma Recent Developments/Updates
Table 75. Nemera Company Information
Table 76. Nemera Description and Business Overview
Table 77. Nemera Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Nemera Pulmonary Administration Product
Table 79. Nemera Recent Developments/Updates
Table 80. Porex Company Information
Table 81. Porex Description and Business Overview
Table 82. Porex Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Porex Pulmonary Administration Product
Table 84. Porex Recent Developments/Updates
Table 85. Chiesi Farmaceutici Company Information
Table 86. Chiesi Farmaceutici Description and Business Overview
Table 87. Chiesi Farmaceutici Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Chiesi Farmaceutici Pulmonary Administration Product
Table 89. Chiesi Farmaceutici Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. AstraZeneca Pulmonary Administration Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. H&T Presspart Company Information
Table 96. H&T Presspart Description and Business Overview
Table 97. H&T Presspart Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. H&T Presspart Pulmonary Administration Product
Table 99. H&T Presspart Recent Developments/Updates
Table 100. Gerresheimer Company Information
Table 101. Gerresheimer Description and Business Overview
Table 102. Gerresheimer Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Gerresheimer Pulmonary Administration Product
Table 104. Gerresheimer Recent Developments/Updates
Table 105. Merxin Ltd Company Information
Table 106. Merxin Ltd Description and Business Overview
Table 107. Merxin Ltd Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Merxin Ltd Pulmonary Administration Product
Table 109. Merxin Ltd Recent Developments/Updates
Table 110. 3M Company Information
Table 111. 3M Description and Business Overview
Table 112. 3M Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. 3M Pulmonary Administration Product
Table 114. 3M Recent Developments/Updates
Table 115. Aerogen Pharma Company Information
Table 116. Aerogen Pharma Description and Business Overview
Table 117. Aerogen Pharma Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Aerogen Pharma Pulmonary Administration Product
Table 119. Aerogen Pharma Recent Developments/Updates
Table 120. MedPharm Company Information
Table 121. MedPharm Description and Business Overview
Table 122. MedPharm Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. MedPharm Pulmonary Administration Product
Table 124. MedPharm Recent Developments/Updates
Table 125. Kindeva Drug Delivery Company Information
Table 126. Kindeva Drug Delivery Description and Business Overview
Table 127. Kindeva Drug Delivery Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Kindeva Drug Delivery Pulmonary Administration Product
Table 129. Kindeva Drug Delivery Recent Developments/Updates
Table 130. Boehringer Ingelheim Company Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Boehringer Ingelheim Pulmonary Administration Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. Chiesi Farmaceutici SpA Company Information
Table 136. Chiesi Farmaceutici SpA Description and Business Overview
Table 137. Chiesi Farmaceutici SpA Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Chiesi Farmaceutici SpA Pulmonary Administration Product
Table 139. Chiesi Farmaceutici SpA Recent Developments/Updates
Table 140. Merck & Co, Inc Company Information
Table 141. Merck & Co, Inc Description and Business Overview
Table 142. Merck & Co, Inc Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Merck & Co, Inc Pulmonary Administration Product
Table 144. Merck & Co, Inc Recent Developments/Updates
Table 145. Novartis AG Company Information
Table 146. Novartis AG Description and Business Overview
Table 147. Novartis AG Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Novartis AG Pulmonary Administration Product
Table 149. Novartis AG Recent Developments/Updates
Table 150. PARI international Company Information
Table 151. PARI international Description and Business Overview
Table 152. PARI international Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. PARI international Pulmonary Administration Product
Table 154. PARI international Recent Developments/Updates
Table 155. Vectura Group Plc Company Information
Table 156. Vectura Group Plc Description and Business Overview
Table 157. Vectura Group Plc Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Vectura Group Plc Pulmonary Administration Product
Table 159. Vectura Group Plc Recent Developments/Updates
Table 160. GlaxoSmithKline Company Information
Table 161. GlaxoSmithKline Description and Business Overview
Table 162. GlaxoSmithKline Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. GlaxoSmithKline Pulmonary Administration Product
Table 164. GlaxoSmithKline Recent Developments/Updates
Table 165. Koninklijke Philips NV Company Information
Table 166. Koninklijke Philips NV Description and Business Overview
Table 167. Koninklijke Philips NV Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Koninklijke Philips NV Pulmonary Administration Product
Table 169. Koninklijke Philips NV Recent Developments/Updates
Table 170. OMRON Corporation Company Information
Table 171. OMRON Corporation Description and Business Overview
Table 172. OMRON Corporation Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. OMRON Corporation Pulmonary Administration Product
Table 174. OMRON Corporation Recent Developments/Updates
Table 175. Sunovion Pharmaceuticals, Inc Company Information
Table 176. Sunovion Pharmaceuticals, Inc Description and Business Overview
Table 177. Sunovion Pharmaceuticals, Inc Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Sunovion Pharmaceuticals, Inc Pulmonary Administration Product
Table 179. Sunovion Pharmaceuticals, Inc Recent Developments/Updates
Table 180. Teva Pharmaceutical Industries Ltd Company Information
Table 181. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 182. Teva Pharmaceutical Industries Ltd Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Teva Pharmaceutical Industries Ltd Pulmonary Administration Product
Table 184. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 185. Yisuo Intelligent Company Information
Table 186. Yisuo Intelligent Description and Business Overview
Table 187. Yisuo Intelligent Pulmonary Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. Yisuo Intelligent Pulmonary Administration Product
Table 189. Yisuo Intelligent Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Pulmonary Administration Distributors List
Table 193. Pulmonary Administration Customers List
Table 194. Pulmonary Administration Market Trends
Table 195. Pulmonary Administration Market Drivers
Table 196. Pulmonary Administration Market Challenges
Table 197. Pulmonary Administration Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pulmonary Administration
Figure 2. Global Pulmonary Administration Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pulmonary Administration Market Share by Type: 2025 & 2032
Figure 4. Pressurized Metered Dose Inhalation System Product Picture
Figure 5. Dry Powder Inhalation System Product Picture
Figure 6. Soft Mist Inhalation System Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pulmonary Administration Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Pulmonary Administration Market Share by Application: 2025 & 2032
Figure 10. Bronchial Asthma
Figure 11. Chronic Obstructive Pulmonary Disease
Figure 12. Others
Figure 13. Global Pulmonary Administration Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Pulmonary Administration Market Size (US$ Million), 2021–2032
Figure 15. Global Pulmonary Administration Sales (K Units), 2021–2032
Figure 16. Global Pulmonary Administration Average Price (US$/Unit), 2021–2032
Figure 17. Pulmonary Administration Report Years Considered
Figure 18. Pulmonary Administration Sales Share by Manufacturers in 2025
Figure 19. Global Pulmonary Administration Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Pulmonary Administration Players: Market Share by Revenue in Pulmonary Administration in 2025
Figure 21. Pulmonary Administration Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Pulmonary Administration Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Pulmonary Administration Sales Market Share by Country (2021–2032)
Figure 24. North America Pulmonary Administration Revenue Market Share by Country (2021–2032)
Figure 25. United States Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Pulmonary Administration Sales Market Share by Country (2021–2032)
Figure 28. Europe Pulmonary Administration Revenue Market Share by Country (2021–2032)
Figure 29. Germany Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Pulmonary Administration Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Pulmonary Administration Revenue Market Share by Region (2021–2032)
Figure 36. China Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Pulmonary Administration Sales Market Share by Country (2021–2032)
Figure 44. Latin America Pulmonary Administration Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Pulmonary Administration Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Pulmonary Administration Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Pulmonary Administration Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Pulmonary Administration by Type (2021–2032)
Figure 55. Global Revenue Market Share of Pulmonary Administration by Type (2021–2032)
Figure 56. Global Pulmonary Administration Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Pulmonary Administration by Application (2021–2032)
Figure 58. Global Revenue Market Share of Pulmonary Administration by Application (2021–2032)
Figure 59. Global Pulmonary Administration Price (US$/Unit) by Application (2021–2032)
Figure 60. Pulmonary Administration Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
